Search filters

List of works by Martin J Edelman

A Phase II Study of Halichondrin B Analog Eribulin Mesylate (E7389) in Patients with Advanced Non-small Cell Lung Cancer Previously Treated with a Taxane: A California Cancer Consortium Trial

scientific article published on March 1, 2012

Anti-HDGF Targets Cancer and Cancer Stromal Stem Cells Resistant to Chemotherapy

scientific article published on May 21, 2013

Benchmarks for Academic Oncology Faculty

scientific article published on 30 September 2020

CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell Lung Cancer in a Prospective Trial: CALGB 150304

scientific article published on April 1, 2012

Cell cycle-dependent potentiation of cisplatin by UCN-01 in non-small-cell lung carcinoma

scientific article published on March 25, 2003

Clinical and pharmacologic study of tributyrin: an oral butyrate prodrug

scientific article published on March 12, 2003

Do older patients with non-small cell lung cancer also benefit from first-line platinum-based doublet chemotherapy? Observations from a pooled analysis of 730 prospectively-treated patients (Alliance Study A151622)

scientific article published on 27 May 2018

EML4/ALK and ras inhibitors

scientific article published on December 1, 2010

Effect of novel benzoylphenylurea derivatives on DNA polymerase α activity using the synthesome-based in vitro model system

scientific article published on November 1, 2003

Epothilones in Development for Non–Small-Cell Lung Cancer: Novel Anti-Tubulin Agents With the Potential to Overcome Taxane Resistance

scientific article published on May 19, 2011

Follow-up testing after cancer treatment: is it indicated?

scientific article published on June 1, 1998

Multicenter Phase II Trial of Motexafin Gadolinium and Pemetrexed for Second-Line Treatment in Patients with Non-small Cell Lung Cancer

scientific article published on April 1, 2011

Multicenter Trial of EC145 in Advanced, Folate-Receptor Positive Adenocarcinoma of the Lung

scientific article published on October 1, 2012

Novel, Broad Spectrum Anticancer Agents Containing the Tricyclic 5:7:5-Fused Diimidazodiazepine Ring System

scientific article published on December 31, 2010

Phase I Study of Folate Conjugate EC145 (Vintafolide) in Patients With Refractory Solid Tumors

scientific article published on November 10, 2012

Phase I trial of edatrexate plus carboplatin in advanced solid tumors: amelioration of dose-limiting mucositis by ice chip cryotherapy

scientific article published on January 1, 1998

Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma

scientific article published on October 1, 1997

Phase II trial of edatrexate plus carboplatin in metastatic non-small-cell lung cancer: a Southwest Oncology Group study

scientific article published on January 1, 1997

Randomized Phase II Study of Ixabepilone or Paclitaxel Plus Carboplatin in Patients With Non–Small-Cell Lung Cancer Prospectively Stratified by Beta-3 Tubulin Status

scientific article published on April 15, 2013

Serum Vascular Endothelial Growth Factor and COX-2/5-LOX Inhibition in Advanced Non-small Cell Lung Cancer: Cancer and Leukemia Group B 150304

scientific article published on November 1, 2011

Small cell lung cancer: current status of new chemotherapeutic agents

scientific article published on April 1, 1998

Structure-based drug design and potent anti-cancer activity of tricyclic 5:7:5-fused diimidazo[4,5-d:4′,5′-f][1,3]diazepines

scientific article published on December 11, 2012

Time-to-Treatment-Failure and Related Outcomes Among 1000+ Advanced Non-Small Cell Lung Cancer Patients: Comparisons Between Older Versus Younger Patients (Alliance A151711).

scientific article published on 30 March 2018